Clinical trials
Phase 4 HIV Infections trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China National Biotec Group Company Limited | 3 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | 2 |
| Makerere University | 2 |
| 407 Doctors | 1 |
| A.O. Ospedale Papa Giovanni XXIII | 1 |
| Aghia Sophia Children's Hospital of Athens | 1 |
| Agouron Pharmaceuticals | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 51 |
| Acquired Immunodeficiency Syndrome | 8 |
| COVID-19 | 3 |
| Obesity | 3 |
| HIV-Associated Lipodystrophy Syndrome | 2 |
| Lipodystrophy | 2 |
| Opioid-Related Disorders | 2 |
| Weight Gain | 2 |
| Atherosclerosis | 1 |
| Coinfection | 1 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.